AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013
Nov 5, 2013
30339_dirs_2013-11-05_fe7146c7-7a7b-4ed1-94e9-b8ba7bfbf9eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-11-04
Reporting Person: LUZZI RICHARD D (Sr. VP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-04 | Common Stock | M | 22000.0000 | $12.7650 | Acquired | 107501.0803 | Direct |
| 2013-11-04 | Common Stock | M | 16708.0000 | $16.2925 | Acquired | 124209.0803 | Direct |
| 2013-11-04 | Common Stock | S | 16708.0000 | $46.9944 | Disposed | 107501.0803 | Direct |
| 2013-11-04 | Common Stock | S | 22000.0000 | $46.9944 | Disposed | 85501.0803 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-04 | Stock Option (Right to Buy) | $16.2925 | M | 16708.0000 | Disposed | 2016-02-24 | Common Stock (16708.0000) | Direct |
| 2013-11-04 | Stock Option (Right to Buy) | $12.7650 | M | 22000.0000 | Disposed | 2015-03-09 | Common Stock (22000.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 952.7700 | Indirect |
| Common Stock | 22622.8264 | Indirect |
Footnotes
F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27